Skip to Content

Join the 'Zohydro' group to help and get support from people like you.

Zohydro News

Zogenix Receives FDA Approval for New Abuse-Deterrent Formulation of Zohydro ER

Posted 30 Jan 2015 by

SAN DIEGO, Jan. 30, 2015 – Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has approved a new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek™. BeadTek is a formulation t ...

Ask a Question